{"id":2138,"date":"2020-03-26T13:25:00","date_gmt":"2020-03-26T13:25:00","guid":{"rendered":"https:\/\/negargetni.com\/?p=2138"},"modified":"2024-09-04T08:51:43","modified_gmt":"2024-09-04T08:51:43","slug":"integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ","status":"publish","type":"post","link":"https:\/\/integragen.com\/en\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/","title":{"rendered":"INTEGRAGEN ANNOUNCES AN AGREEMENT WITH A LEADING US CANCER CENTER FOR THE USE OF MERCURY\u2122, THE ONCOLOGY SEQUENCING DATA INTERPRETATION AND REPORTING TOOL"},"content":{"rendered":"<p><\/p>\n\n\n\n<p>IntegraGen announced today that Dana Farber Cancer Institute will use MERCURYTM, IntegraGen's proprietary software, in their analysis and reporting of tumor sequencing data from cancer patients. Dana Farber plans to use MERCURY for the analysis of targeted gene panel sequences, as well as data obtained from exome and whole genome sequencing.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.businesswire.com\/news\/home\/20200326005547\/fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">To the press release<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<p>March 26, 2020<\/p>\n\n\n\n<p>Share :<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"\/en\/actualite\/covid-19-des-mesures-pour-assurer-la-protection-de-tous-et-le-bon-deroulement-de-vos-projets\/\">COVID-19: Measures to protect everyone and ensure your projects run smoothly<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/actualites\/integragen-update-toujours-ouverts-pour-projets\/\">IntegraGen Update - Always open for your projects<\/a><\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>IntegraGen announced today that Dana Farber Cancer Institute will use MERCURYTM, IntegraGen's proprietary software, in their process of analyzing and reporting tumor sequencing data from cancer patients. Dana Farber plans to use MERCURY for the analysis of targeted gene panel sequences, as well as data obtained from...<\/p>","protected":false},"author":1,"featured_media":2783,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ca_portfolio_gallery_project_year":"","ca_portfolio_gallery_client":"","ca_portfolio_gallery_skills":"","ca_portfolio_gallery_url":"","ca_portfolio_gallery_images":"","_eb_attr":"","footnotes":""},"categories":[6,1],"tags":[],"class_list":["post-2138","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communiques-de-presse","category-toutes-les-categories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE<\/title>\n<meta name=\"description\" content=\"IntegraGen annonce aujourd\u2019hui que le Dana Farber Cancer Institute utilisera MERCURYTM, le logiciel propri\u00e9taire d\u2019IntegraGen, dans leur processus\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/integragen.com\/en\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE\" \/>\n<meta property=\"og:description\" content=\"IntegraGen annonce aujourd\u2019hui que le Dana Farber Cancer Institute utilisera MERCURYTM, le logiciel propri\u00e9taire d\u2019IntegraGen, dans leur processus\" \/>\n<meta property=\"og:url\" content=\"https:\/\/integragen.com\/en\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/\" \/>\n<meta property=\"og:site_name\" content=\"IntegraGen\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-26T13:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-04T08:51:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/integragen.com\/wp-content\/uploads\/2020\/03\/mercury-logo-300x3002-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"borel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"borel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/\"},\"author\":{\"name\":\"borel\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\"},\"headline\":\"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE\",\"datePublished\":\"2020-03-26T13:25:00+00:00\",\"dateModified\":\"2024-09-04T08:51:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/\"},\"wordCount\":148,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/mercury-logo-300x3002-1.png\",\"articleSection\":[\"Communiqu\u00e9s de presse\",\"Toutes les Cat\u00e9gories\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/\",\"name\":\"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/mercury-logo-300x3002-1.png\",\"datePublished\":\"2020-03-26T13:25:00+00:00\",\"dateModified\":\"2024-09-04T08:51:43+00:00\",\"description\":\"IntegraGen annonce aujourd\u2019hui que le Dana Farber Cancer Institute utilisera MERCURYTM, le logiciel propri\u00e9taire d\u2019IntegraGen, dans leur processus\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#primaryimage\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/mercury-logo-300x3002-1.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/mercury-logo-300x3002-1.png\",\"width\":300,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/integragen.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9s de presse\",\"item\":\"https:\\\/\\\/integragen.com\\\/communiques-de-presse\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"name\":\"IntegraGen - Clinical Genomic Experts\",\"description\":\"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CRO\",\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"alternateName\":\"IntegraGen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/integragen.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\",\"name\":\"IntegraGen\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"width\":2478,\"height\":684,\"caption\":\"IntegraGen\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/integragen\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\",\"name\":\"borel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"caption\":\"borel\"},\"sameAs\":[\"http:\\\/\\\/nouveausiteintegragen2.local\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INTEGRAGEN ANNOUNCES AN AGREEMENT WITH A LEADING US CANCER CENTER FOR THE USE OF MERCURY\u2122, THE ONCOLOGY SEQUENCING DATA INTERPRETATION AND REPORTING TOOL","description":"IntegraGen annonce aujourd\u2019hui que le Dana Farber Cancer Institute utilisera MERCURYTM, le logiciel propri\u00e9taire d\u2019IntegraGen, dans leur processus","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/integragen.com\/en\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/","og_locale":"en_US","og_type":"article","og_title":"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE","og_description":"IntegraGen annonce aujourd\u2019hui que le Dana Farber Cancer Institute utilisera MERCURYTM, le logiciel propri\u00e9taire d\u2019IntegraGen, dans leur processus","og_url":"https:\/\/integragen.com\/en\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/","og_site_name":"IntegraGen","article_published_time":"2020-03-26T13:25:00+00:00","article_modified_time":"2024-09-04T08:51:43+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/03\/mercury-logo-300x3002-1.png","type":"image\/png"}],"author":"borel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"borel","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#article","isPartOf":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/"},"author":{"name":"borel","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8"},"headline":"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE","datePublished":"2020-03-26T13:25:00+00:00","dateModified":"2024-09-04T08:51:43+00:00","mainEntityOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/"},"wordCount":148,"commentCount":0,"publisher":{"@id":"https:\/\/integragen.com\/#organization"},"image":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#primaryimage"},"thumbnailUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/03\/mercury-logo-300x3002-1.png","articleSection":["Communiqu\u00e9s de presse","Toutes les Cat\u00e9gories"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/","url":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/","name":"INTEGRAGEN ANNOUNCES AN AGREEMENT WITH A LEADING US CANCER CENTER FOR THE USE OF MERCURY\u2122, THE ONCOLOGY SEQUENCING DATA INTERPRETATION AND REPORTING TOOL","isPartOf":{"@id":"https:\/\/integragen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#primaryimage"},"image":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#primaryimage"},"thumbnailUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/03\/mercury-logo-300x3002-1.png","datePublished":"2020-03-26T13:25:00+00:00","dateModified":"2024-09-04T08:51:43+00:00","description":"IntegraGen annonce aujourd\u2019hui que le Dana Farber Cancer Institute utilisera MERCURYTM, le logiciel propri\u00e9taire d\u2019IntegraGen, dans leur processus","breadcrumb":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#primaryimage","url":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/03\/mercury-logo-300x3002-1.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/03\/mercury-logo-300x3002-1.png","width":300,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/integragen.com\/toutes-les-categories\/integragen-annonce-un-accord-avec-un-centre-de-cancerologie-us-de-reference-pour-lutilisation-de-mercury-loutil-dinterpretation-et-de-reporting-des-donnees-de-sequ\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/integragen.com\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9s de presse","item":"https:\/\/integragen.com\/communiques-de-presse\/"},{"@type":"ListItem","position":3,"name":"INTEGRAGEN ANNONCE UN ACCORD AVEC UN CENTRE DE CANC\u00c9ROLOGIE US DE R\u00c9F\u00c9RENCE POUR L\u2019UTILISATION DE MERCURY\u2122, L\u2019OUTIL D\u2019INTERPR\u00c9TATION ET DE REPORTING DES DONN\u00c9ES DE S\u00c9QUEN\u00c7AGE EN CANC\u00c9ROLOGIE"}]},{"@type":"WebSite","@id":"https:\/\/integragen.com\/#website","url":"https:\/\/integragen.com\/","name":"IntegraGen - Clinical Genomic Experts","description":"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CROs","publisher":{"@id":"https:\/\/integragen.com\/#organization"},"alternateName":"IntegraGen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/integragen.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/integragen.com\/#organization","name":"IntegraGen","url":"https:\/\/integragen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/","url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","width":2478,"height":684,"caption":"IntegraGen"},"image":{"@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/integragen\/"]},{"@type":"Person","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8","name":"borel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","caption":"borel"},"sameAs":["http:\/\/nouveausiteintegragen2.local"]}]}},"_links":{"self":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/comments?post=2138"}],"version-history":[{"count":3,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2138\/revisions"}],"predecessor-version":[{"id":2143,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2138\/revisions\/2143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media\/2783"}],"wp:attachment":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media?parent=2138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/categories?post=2138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/tags?post=2138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}